Literature DB >> 31213525

A temperature-dependent conformational shift in p38α MAPK substrate-binding region associated with changes in substrate phosphorylation profile.

Daniel Deredge1, Patrick L Wintrode1, Mohan E Tulapurkar2, Ashish Nagarsekar2, Yinghua Zhang3, David J Weber4, Paul Shapiro1, Jeffrey D Hasday5,6.   

Abstract

Febrile-range hyperthermia worsens and hypothermia mitigates lung injury, and temperature dependence of lung injury is blunted by inhibitors of p38 mitogen-activated protein kinase (MAPK). Of the two predominant p38 isoforms, p38α is proinflammatory and p38β is cytoprotective. Here, we analyzed the temperature dependence of p38 MAPK activation, substrate interaction, and tertiary structure. Incubating HeLa cells at 39.5 °C stimulated modest p38 activation, but did not alter tumor necrosis factor-α (TNFα)-induced p38 activation. In in vitro kinase assays containing activated p38α and MAPK-activated kinase-2 (MK2), MK2 phosphorylation was 14.5-fold greater at 39.5 °C than at 33 °C. By comparison, we observed only 3.1- and 1.9-fold differences for activating transcription factor-2 (ATF2) and signal transducer and activator of transcription-1α (STAT1α) and a 7.7-fold difference for p38β phosphorylation of MK2. The temperature dependence of p38α:substrate binding affinity, as measured by surface plasmon resonance, paralleled substrate phosphorylation. Hydrogen-deuterium exchange MS (HDX-MS) of p38α performed at 33, 37, and 39.5 °C indicated temperature-dependent conformational changes in an α helix near the common docking and glutamate:aspartate substrate-binding domains at the known binding site for MK2. In contrast, HDX-MS analysis of p38β did not detect significant temperature-dependent conformational changes in this region. We observed no conformational changes in the catalytic domain of either isoform and no corresponding temperature dependence in the C-terminal p38α-interacting region of MK2. Because MK2 participates in the pathogenesis of lung injury, the observed changes in the structure and function of proinflammatory p38α may contribute to the temperature dependence of acute lung injury.

Entities:  

Keywords:  MAPKAPK-2; hydrogen-deuterium exchange; hyperthermia; p38 MAPK; protein structure; pulmonary damage; pyrogen; signaling; substrate specificity; substrate-docking site; temperature-dependence

Mesh:

Substances:

Year:  2019        PMID: 31213525      PMCID: PMC6709627          DOI: 10.1074/jbc.RA119.007525

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha.

Authors:  Baoxue Ge; Hermann Gram; Franco Di Padova; Betty Huang; Liguo New; Richard J Ulevitch; Ying Luo; Jiahuai Han
Journal:  Science       Date:  2002-02-15       Impact factor: 47.728

Review 2.  Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.

Authors:  D W Hommes; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  The p38 mitogen-activated protein kinase mediates cytoskeletal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation.

Authors:  Q Wang; C M Doerschuk
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

4.  Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability.

Authors:  Joe G N Garcia; Peiyi Wang; Kane L Schaphorst; Patrice M Becker; Talaibek Borbiev; Feng Liu; Anna Birukova; Keri Jacobs; Natalia Bogatcheva; Alexander D Verin
Journal:  FASEB J       Date:  2002-07       Impact factor: 5.191

5.  Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions.

Authors:  T Tanoue; R Maeda; M Adachi; E Nishida
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

6.  Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo.

Authors:  D C Cara; J Kaur; M Forster; D M McCafferty; P Kubes
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

7.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.

Authors: 
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

8.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.

Authors:  Stephen A Bernard; Timothy W Gray; Michael D Buist; Bruce M Jones; William Silvester; Geoff Gutteridge; Karen Smith
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

9.  Effects of moderate hypothermia on IL-1 beta-induced leukocyte rolling and adhesion in pial microcirculation of mice and on proinflammatory gene expression in human cerebral endothelial cells.

Authors:  I T Sutcliffe; H A Smith; D Stanimirovic; J S Hutchison
Journal:  J Cereb Blood Flow Metab       Date:  2001-11       Impact factor: 6.200

10.  Regulation of tissue factor in microvascular dermal endothelial cells.

Authors:  Fiona M O'Reilly; Katherine A Casper; Kristen B Otto; Shenara A Sexton; R A Swerlick
Journal:  J Invest Dermatol       Date:  2003-03       Impact factor: 8.551

View more
  3 in total

1.  Thermodynamic analysis of the binding of p38 MAPK to substrate proteins.

Authors:  Mehvish K Durrani; Jonghoon Kang
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

Review 2.  Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.

Authors:  Ellie I James; Taylor A Murphree; Clint Vorauer; John R Engen; Miklos Guttman
Journal:  Chem Rev       Date:  2021-09-07       Impact factor: 72.087

3.  Identification of Thermal Conduits That Link the Protein-Water Interface to the Active Site Loop and Catalytic Base in Enolase.

Authors:  Emily J Thompson; Adhayana Paul; Anthony T Iavarone; Judith P Klinman
Journal:  J Am Chem Soc       Date:  2021-01-04       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.